Abstract
<h3>To the Editor.—</h3> As a minor participant in the University Group Diabetes Program (UGDP), I think that the compelling reason for the study apparently has been lost (1) in the controversy over the validity of the reported finding of increased cardiovascular deaths in patients receiving tolbutamide, and (2) in the criticism of the Food and Drug Administration's bulletin to physicians with respect to its recommendations concerning the use of orally administered hypoglycemic agents. The Program was undertaken to evaluate prospectively the influence of treatment upon the development of complications in adult-onset diabetics. This basic question, so vital to the day-to-day care of diabetic patients, has not been answered to date by the Program. Both patients and their attending physicians are entitled to an answer; hence, this letter. Currently the Executive Committee of the UGDP is in process of preparation of a request to the National Institutes of Health to continue
Keywords
Related Publications
The University Group Diabetes Program
The basic conclusion of University Group Diabetes Program on tolbutamide is: the findings of this study indicate that combination of diet and tolbutamide therapy is no more ef...
Plasma Insulin Responses to Glucose and Tolbutamide of Normal Weight and Obese Diabetic and Nondiabetic Subjects
Plasma insulin responses to oral glucose (100 gm.) and intravenous tolbutamide (1.0 gm.) before and after dexamethasone were determined in normal, obese nondiabetic, normal-weig...
Implications of generalists' slow adoption of zidovudine in clinical practice
<h3>Background:</h3> The lag time for adoption of new acquired immunodeficiency syndrome (AIDS) therapies into the clinical practices of different types of ambulatory care provi...
Health Promotion and Disease Prevention in the Elderly
The purpose of this study was to evaluate and compare attending physician and house staff attitudes and practices regarding health promotion and disease prevention in the elderl...
Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study
<h3>Objective.</h3> —To assess the validity and utility of PRIME-MD (Primary Care Evaluation of Mental Disorders), a new rapid procedure for diagnosing mental disorders by prima...
Publication Info
- Year
- 1971
- Type
- article
- Volume
- 215
- Issue
- 13
- Pages
- 2115-2115
- Citations
- 116
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1001/jama.1971.03180260057027